Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ACRS compared with IPSC: revenue, margins and what each company keeps, and the suppliers and customers both name
ACRS
Aclaris Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
IPSC
Century Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ACRS
Aclaris Therapeutics, Inc.
vs
IPSC
Century Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ACRS, solid
IPSC, dashed
ACRS
Aclaris Therapeutics, Inc.
Change
3.98
▼
−0.35%
· post 3.98
Mkt cap
$584.4M
Revenue
$2M
Q2 FY26
Revenue
$8M
FY25
IPSC
Century Therapeutics, Inc.
Change
1.49
▲
+1.76%
· post 1.48
Closed
Oct 30 '26
Mkt cap
$266.2M
Revenue
$109M
Q1 FY25
Revenue
$7M
FY24
vs
Compare
Closed
Oct 30 '26
ACRS
Aclaris Therapeutics, Inc.
vs
IPSC
Century Therapeutics, Inc.
3.98
▼
−0.35%
post 3.98
Price
1.49
▲
+1.76%
post 1.48
$584.4M
Mkt cap
$266.2M
Q2 FY26
$2M
Revenue
$109M
Q1 FY25
FY25
$8M
Revenue
$7M
FY24
Change
Change
ACRS
3.98
▼
−0.35%
vs
IPSC
1.49
▲
+1.76%
Closed
Oct 30 '26